View of THE ROLE OF COMBINED LIPID-LOWERING THERAPY (ROSUVASTATIN/EZETIMIBE) IN THE TREATMENT OF CARDIOVASCULAR DISEASES CAUSED BY ATHEROSCLEROSIS

Return to Article Details THE ROLE OF COMBINED LIPID-LOWERING THERAPY (ROSUVASTATIN/EZETIMIBE) IN THE TREATMENT OF CARDIOVASCULAR DISEASES CAUSED BY ATHEROSCLEROSIS Download Download PDF